Premier Partners logo

Premier Partners

Asia, Seoul-t'ukpyolsi, South Korea, Seoul

Description

Premier Partners is a prominent South Korean investment firm headquartered in Seoul, recognized for its dual focus on venture capital (VC) and private equity (PE). Established as a domestic funds management company, it has grown to become a significant player in the Korean investment landscape, providing capital and strategic support to a diverse range of companies.

The firm employs a comprehensive investment strategy, targeting high-growth opportunities across various sectors including technology, media, telecommunications, healthcare, and consumer goods. Premier Partners invests across different stages of a company's lifecycle, from early-stage startups requiring initial venture capital to more mature, pre-IPO companies seeking growth equity. As of late 2023, Premier Partners manages assets exceeding ₩2 trillion, equivalent to approximately $1.5 billion USD, underscoring its substantial financial capacity and market presence.

Premier Partners' "two-track" approach allows for flexibility in its investment size and scope. For its venture capital arm, typical first cheques are directed towards promising early to mid-stage companies. Concurrently, its private equity division focuses on larger, more established businesses, often providing significant capital for expansion, strategic acquisitions, or pre-IPO rounds. For instance, the firm successfully raised a ₩200 billion (approximately $150 million USD) growth-focused fund in 2022, demonstrating its commitment to scaling innovative companies. This dual strategy enables Premier Partners to cater to a broad spectrum of investment opportunities, from nascent ventures to market leaders.

Investor Profile

Premier Partners has backed more than 27 startups, with 9 new investments in the last 12 months alone. The firm has led 3 rounds, about 11% of its total and boasts 20 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series A, Series Unknown rounds (top funding stages).
  • Majority of deals are located in South Korea, United States.
  • Strong thematic focus on Artificial Intelligence (AI), Biotechnology, Health Care.
  • Led 1 rounds in the past year.
  • Typical check size: $1M – $30M.

Stage Focus

  • Series B (44%)
  • Series A (30%)
  • Series Unknown (11%)
  • Series C (11%)
  • Corporate Round (4%)

Country Focus

  • South Korea (63%)
  • United States (30%)

Industry Focus

  • Artificial Intelligence (Ai)
  • Biotechnology
  • Health Care
  • Machine Learning
  • Software
  • Therapeutics
  • Natural Language Processing
  • Beauty
  • E-commerce
  • Computer Vision
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Premier Partners frequently co-invest with?

Johnson & Johnson Innovation – JJDC
North America, Massachusetts, United States, Cambridge
Co-Investments: 2
Korea Development Bank
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 3
DSC Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 5
Korea Investment Partners
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 3
Aju IB Investment
Asia, Seoul-t'ukpyolsi, South Korea, Yeoksamdong
Co-Investments: 3
Shinhan Venture Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 4
Kiwoom Investment
Asia, Seoul-t'ukpyolsi, South Korea, Youidodong
Co-Investments: 3
Company K Partners
Asia, Seoul-t'ukpyolsi, South Korea, Ilsangu
Co-Investments: 3
KT Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 5
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 2

What are some of recent deals done by Premier Partners?

Upstage

Yongin, Ch'ungch'ong-namdo, South Korea

Upstage is an AI-driven language models and document processing engines that streamline data extraction, analysis, and workflow management.

Artificial Intelligence (AI)Machine LearningNatural Language ProcessingPredictive AnalyticsSoftware
Series BAug 19, 2025
Amount Raised: $44,619,287
Law&Company

Seoul, Seoul-t'ukpyolsi, South Korea

Law&Company provide LawTalk service to solve information asymmetry and illegal legal broker of Korean legal market.

Information ServicesLaw EnforcementLegalLegal Tech
Series CJul 15, 2025
Amount Raised: $36,206,333
Celltrio

Fremont, California, United States

Celltrio is a manufacturer of cell culturing automation and biobanking solutions.

Information TechnologyManufacturingRobotics
Series UnknownJun 17, 2025
Amount Raised: $15,000,000

Medisolar, a customized food care solution company

Health CareNutrition
Series AApr 3, 2025
Amount Raised: $8,859,520
Prazer Therapeutics

Seoul, Seoul-t'ukpyolsi, South Korea

Prazer Therapeutics is a biotechnology company that generates novel therapeutics for refractory diseases.

BiotechnologyPharmaceuticalTherapeutics
Series BApr 1, 2025
Amount Raised: $19,728,977
Gangnam Unni

Seoul, Seoul-t'ukpyolsi, South Korea

Gangnam Unni is in the field of beauty medical services, helping users choose a treatment and plastic surgery hospital.

BeautyCosmetic SurgeryMedicalWellness
Series CFeb 17, 2025
Amount Raised: $29,702,535
Healing Paper

Seocho, Seoul-t'ukpyolsi, South Korea

Healing Paper uses ICT to improve medical service access, reduce costs, and balance information between experts and non-experts.

BeautyHealth CareMedicalmHealth
Series CFeb 17, 2025
Amount Raised: $29,702,535

MicrobiotiX develops bacteriophage and microbiome-based therapeutics to combat multidrug-resistant infections and autoimmune diseases.

BiotechnologyHealth CarePharmaceutical
Series BOct 21, 2024
Amount Raised: $10,889,383
AIGEN Sciences

Seoul, Seoul-t'ukpyolsi, South Korea

AIGEN Sciences is an AI drug discovery platform that provides drug research and development services.

Artificial Intelligence (AI)BiotechnologyPharmaceuticalProduct Research
Series AOct 16, 2024
Amount Raised: $8,794,744
Lucas

Yeoksamdong, Seoul-t'ukpyolsi, South Korea

Lucas develops a system to detect, measure, categorize and track nodules in the screening CT images.

Medical DeviceSoftware
Series BOct 2, 2024
Amount Raised: $5,282,560